Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models.

Summary
Title
Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models.
Authors
  • Porter LH
  • Zhu JJ
  • Lister NL
  • Harrison SG
  • Keerthikumar S
  • Goode DL
  • Urban RQ
  • Byrne DJ
  • Azad A
  • Vela I
  • Hofman MS
  • Neeson PJ
  • Darcy PK
  • Trapani JA
  • Taylor RA
  • Risbridger GP
Source
Nat Commun
Publication Date
2023 Sep 2
PubMed ID
37660083

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025